DYER TIMOTHY MARK (Chief Executive Officer) received a stock award from ADDEX THERAPEUTICS LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/4/2026ACC: 0001104659-26-105481
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
19.78M acquired · 19.78M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−16.41M
Price / share
—
Trade value
—
% of position
97.4%
9/2/2026
16.85M→435.19K
Common Stock
Direct
Shares
+16.41M
Price / share
—
Trade value
—
% of position
3771.6%
9/2/2026
435.19K→16.85M
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | D · Disposition | −16.41M | — | — | 97.4% | 16.85M | 435.19K |
| Common Stock Direct | 9/2/2026 | A · Award | +16.41M | — | — | 3771.6% | 435.19K | 16.85M |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions2
Stock-option (Right to Buy)
Direct
Converts to
Common Stock
3.37M shares
Shares
−3.37M
Strike price
0.062
Held after
0.00
Exercisable
—
9/2/2026
Stock-option (Right to Buy)
Direct
Converts to
Common Stock
3.37M shares
Shares
+3.37M
Strike price
0.032
Held after
3.37M
Exercisable
—
9/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock-option (Right to Buy) Direct | Common Stock3.37M shares | 9/2/2026 | D · Disposition | −3.37M | 0.062 | — | 0.00 |
| Stock-option (Right to Buy) Direct | Common Stock3.37M shares | 9/2/2026 | A · Award | +3.37M | 0.032 | — | 3.37M |